The Ph.D. Programme in Molecular and Experimental Medicine (MEM) aims to address some of the main challenges of life sciences in a highly competitive scientific research environment.

This 3-year international programme provides advanced training in various fields of life sciences and molecular medicine.

Research Topics
FAQ PhD MEM

Mission

The MEM PhD Programme provides training in various fields of life sciences and molecular medicine offering a stimulating environment with access to state-of-the-art technology and clinical case lists for translational studies.

Starting from academic year 2019-2020 two different curricula will be available; candidate are required to specify their curriculum preferences when applying.

The MEM Curriculum provides for the research activities to develop along, yet not remain limited to, the following main areas, including: oncological immunopathology, molecular cardiometabolics, genetics, neurosciences. An overall vision of regenerative and precision medicine is the theme running throughout the programme. The curriculum provides specific training for enabling technologies, such as imaging, flow cytometry, genomics and bioinformatics.

The MEM-Clinical curriculum aims to combine basic or clinical experimental research activities with clinical practice involving patient enrolment and assessment in specific trials. The course provides for ordinary clinical practice in the hospital under the supervision of a doctor (up to a maximum of 20 hours per week) and experimental laboratory activities, which include but are not limited to cellular and molecular biology, information technology, immunology and the use of preclinical models. Candidates will be directly responsible for research projects approved by their clinical supervisor and/or laboratory head.

For both curricula the PhD will be conducted in a stimulating environment involving the organisation of Journal clubs and seminars given by national and international speakers, participation in congresses, informal meetings between different disciplines, encouraging researchers to work independently and collaboration with groups abroad. Liaising with tutors and non-Italian discussants further develops the international dimension.

PhD Coordinator: Prof Maria Rescigno
Language

English

Duration

3 years

Beginning of the academic year

November 1st, 2019

Future perspectives for Humanitas PhD students

The PhD program aims to train experts in clinical and industrial research, preparing them to take up careers in biotech companies, in translational research, in clinical or academic fields worldwide. Thanks to a “translational” approach, professionals will quickly transfer new knowledge from basic sciences to bio-medicine with the aim of creating new and advanced diagnostic and therapeutic applications.

Admission Requirements

MEM curriculum

Applicants wishing to enrol on the PhD course in Molecular and Experimental Medicine, MEM Curriculum must either have a “laurea magistrale” awarded in accordance with D.M. 270/2004 or equivalent qualification awarded by a foreign university (usually referred to as a Master’s Degree), in one of the subjects listed in the official call for applicants.

Applicants who are waiting to be awarded the required qualification at the date of submission can also take part in the selection process providing they have passed all of the Degree course exams at the time of the online application and are awarded the qualification by the final deadline of September 13th 2019. In the event these applicants pass the selection process, their enrolment on the PhD course is conditional upon providing proof that the qualification is awarded by September 16th 2019.

MEM-Clinical curriculum

Applicants wishing to enrol on the PhD Course in Molecular and Experimental Medicine, MEM-Clinical Curriculum must:

  • be enrolled on the Medical Register;
  • already possess a specialist medical qualification;

– Alternatively, applications will also be taken from doctors in specialist training who will enrol in the final year in a School of Specialisation at Humanitas University;

– Doctors in specialist training who are already enrolled in the final year of Specialisation at any university and who will complete their training by October 31st 2019 may also apply. In the event these applicants pass the selection process, they may conditionally enrol on the PhD Course and are required to provide proof that the qualification is awarded by  November 4th 2019.

Scholarships and fees

The gross annual amount of each scholarship awarded by the University is € 18.000,00 for the MEM curriculum and € 22.400,00 for the MEM-Clinical curriculum, paid in monthly instalments.

PhD students are required to pay an annual fee for access and attendance, set at € 250,00 for the academic year 2019/2020, including the regional tax and stamp duty.

How to Apply

  • Registration or access with your LOGINMIUR credentials
  • Application form submission
  • Payment of the application contribution

The application form must be completed in all its parts, on penalty of exclusion. In particular, applicants must submit all of the following documents in PDF format:

  1. Curriculum vitae
  2. Motivation letter
  3. Copy of a valid ID or passport (for Non-EU citizens)
  4. Diploma Supplement
  5. Copy of the receipt of payment of € 30,00

Additionally, applicants may indicate name and contacts of maximum two referees, preferably chosen among those who have had a supervising role of the candidates. The referees will be directly contacted by Humanitas University and asked to complete a brief letter of reference.

Further details about the application procedure will be reported in the official call for applicants.

Applications for academic year 2019-20 are now closed

Admission process

Admission to the PhD Programme is based on a public selection process consisting of

  • the comparative evaluation of the titles and qualifications and
  • an interview carried out in English by a Committee composed of a maximum of seven members.

The aim of the selection process is to assess the knowledge, competencies and aptitude of the applicants for scientific research as well as their motivation for undertaking the PhD programme.

Prior to the interview, applicants may be asked to take a multiple choice test, aimed at assessing the applicant’s specific knowledge in the fields of the research projects of the Campus.

A good knowledge of English is required and will be tested during the interview.

Should reasons justify it, the test and interview can be conducted via video-conference. Those who intend to conduct the interview via video-conference or request special assistance should specify this on the application form.

The final ranking list will be posted on this page in the week starting on September 16th 2019.

First ranking list with short list for oral interviews

The first ranking list

Due to the high number of outstanding applications, the Commission has extended the number of shortlisted candidates to 58.

The oral inteviews for the shortlisted candidates will take place on September 16th, 17th, 18th 2019. Shortlisted candidates will be contacted via mail.

Academic Board

PhD CoordinatorProfessor Maria Rescigno

2019-2020 available positions and topics

There are 8 positions available.
Additional places and/or scholarships may become available based on external fundings.

The number of available places and/or scholarships may increase in the event that external funding for additional places or scholarships becomes available by the deadline set for the completion of the call application procedure.

 

Research topics

Proposed research topics are listed below; go to the Research Topics section” to read the abstract, the main technical approaches and the scientific references of the project.

HUMANITAS GROUP

Humanitas is a highly specialized Hospital, Research and Teaching Center. Built around centers for the prevention and treatment of cancer, cardiovascular, neurological and orthopedic disease – together with an Ophthalmic Center and a Fertility Center – Humanitas also operates a highly specialised Emergency Department.